{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:42:48Z","timestamp":1791308568488,"version":"4.3.1"},"reference-count":185,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Physiol."],"DOI":"10.3389\/fphys.2016.00124","type":"journal-article","created":{"date-parts":[[2016,4,4]],"date-time":"2016-04-04T23:15:37Z","timestamp":1459811737000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":218,"title":["Poly Cystic Ovarian Syndrome: An Updated Overview"],"prefix":"10.3389","volume":"7","author":[{"given":"Samer","family":"El Hayek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Bitar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Layal H.","family":"Hamdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadi G.","family":"Mirza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges","family":"Daoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2016,4,5]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S0015-0282(16)58266-1","article-title":"Can metformin reduce insulin resistance in polycystic ovary syndrome?","volume":"65","author":"A\u00e7bay","year":"1996","journal-title":"Fertil. Steril."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1210\/jc.2009-2651","article-title":"Infants of women with polycystic ovary syndrome have lower cord blood androstenedione and estradiol levels","volume":"95","author":"Anderson","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1210\/jcem.87.4.8398","article-title":"Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia\/insulin resistance","volume":"87","author":"Arslanian","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B4","doi-asserted-by":"publisher","first-page":"4237","DOI":"10.1210\/jc.2006-0178","article-title":"Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline","volume":"91","author":"Azziz","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B5","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","article-title":"The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report","volume":"91","author":"Azziz","year":"2009","journal-title":"Fertil. Steril."},{"key":"B6","doi-asserted-by":"publisher","first-page":"4650","DOI":"10.1210\/jc.2005-0628","article-title":"Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span","volume":"90","author":"Azziz","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.fertnstert.2006.11.031","article-title":"Effects of oral fat and glucose tolerance test on serum lipid profile, apolipoprotein, and CRP concentration, and insulin resistance in patients with polycystic ovary syndrome","volume":"87","author":"Bahceci","year":"2007","journal-title":"Fertil. Steril."},{"key":"B9","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1159\/000081973","article-title":"Serum C-reactive protein (CRP) levels and insulin resistance in non-obese women with polycystic ovarian syndrome, and effect of bicalutamide on hirsutism, CRP levels and insulin resistance","volume":"62","author":"Bahceci","year":"2004","journal-title":"Horm. Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1056\/NEJM199602293340906","article-title":"Metformin","volume":"334","author":"Bailey","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1097\/00003081-200306000-00011","article-title":"Insulin sensitizers for polycystic ovary syndrome","volume":"46","author":"Baillargeon","year":"2003","journal-title":"Clin. Obstet. Gynecol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"3863","DOI":"10.1210\/jc.2004-1958","article-title":"Association between the current use of low-dose oral contraceptives and cardiovascular arterial disease: a meta-analysis","volume":"90","author":"Baillargeon","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1093\/humrep\/den097","article-title":"Greek hyperinsulinemic women, with or without polycystic ovary syndrome, display altered inositols metabolism","volume":"23","author":"Baillargeon","year":"2008","journal-title":"Hum. Reprod."},{"key":"B14","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1093\/oxfordjournals.humrep.a136243","article-title":"Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients","volume":"10","author":"Balen","year":"1995","journal-title":"Hum. Reprod."},{"key":"B15","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S1521-6934(02)00119-0","article-title":"Polycystic ovary syndrome\u2013a systemic disorder?","volume":"17","author":"Balen","year":"2003","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"B16","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1093\/oxfordjournals.humrep.a138174","article-title":"Miscarriage rates following in vitro fertilization are increased in women with polycystic ovaries and reduced by pituitary desensitization with buserelin","volume":"8","author":"Balen","year":"1993","journal-title":"Hum. Reprod."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1093\/humrep\/dem108","article-title":"Quality of life and psychological well being in polycystic ovary syndrome","volume":"22","author":"Barnard","year":"2007","journal-title":"Hum. Reprod."},{"key":"B18","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/j.1742-1241.2008.01897.x","article-title":"Atherogenic forms of dyslipidaemia in women with polycystic ovary syndrome","volume":"63","author":"Berneis","year":"2009","journal-title":"Int. J. Clin. Pract."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1111\/j.1447-0756.2010.01516.x","article-title":"Prevalence and risk of metabolic syndrome in adolescent Indian girls with polycystic ovary syndrome using the 2009 'joint interim criteria'","volume":"37","author":"Bhattacharya","year":"2011","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1210\/jc.2012-3698","article-title":"Global adiposity and thickness of intraperitoneal and mesenteric adipose tissue depots are increased in women with polycystic ovary syndrome (PCOS)","volume":"98","author":"Borruel","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B21","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s11892-006-0056-1","article-title":"Risk of T2DM and impaired fasting glucose among PCOS subjects: results of an 8-year follow-up","volume":"6","author":"Boudreaux","year":"2006","journal-title":"Curr. Diab. Rep."},{"key":"B22","doi-asserted-by":"publisher","first-page":"3835","DOI":"10.1210\/jc.2003-031737","article-title":"Effect of the insulin sensitizer pioglitazone on insulin resistance, hyperandrogenism, and ovulatory dysfunction in women with polycystic ovary syndrome","volume":"89","author":"Brettenthaler","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B23","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.gyobfe.2014.01.001","article-title":"Polycystic ovary syndrome: what are the obstetrical risks?","volume":"42","author":"Bruyneel","year":"2014","journal-title":"Gynecol. Obstet. Fertil."},{"key":"B24","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1210\/jcem-50-1-113","article-title":"Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease","volume":"50","author":"Burghen","year":"1980","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e201","DOI":"10.1016\/j.ajog.2010.03.008","article-title":"The diagnosis of polycystic ovary syndrome in adolescents","volume":"203","author":"Carmina","year":"2010","journal-title":"Am. J. Obstet. Gynecol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jpeds.2003.10.032","article-title":"Polycystic ovary syndrome: what is it and how should we treat it?","volume":"144","author":"Cedars","year":"2004","journal-title":"J. Pediatr."},{"key":"B27","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/ng.732","article-title":"Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3","volume":"43","author":"Chen","year":"2011","journal-title":"Nat. Genet."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.1210\/jc.2004-2359","article-title":"Progesterone inhibition of the hypothalamic gonadotropin-releasing hormone pulse generator: evidence for varied effects in hyperandrogenemic adolescent girls","volume":"90","author":"Chhabra","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B29","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/S1472-6483(10)60175-7","article-title":"Polycystic ovary syndrome and the risk of gynaecological cancer: a systematic review","volume":"19","author":"Chittenden","year":"2009","journal-title":"Reprod. Biomed. Online"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1093\/humrep\/13.6.1502","article-title":"Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment","volume":"13","author":"Clark","year":"1998","journal-title":"Hum. Reprod."},{"key":"B31","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1210\/jc.2006-1665","article-title":"Differential gene expression profile in omental adipose tissue in women with polycystic ovary syndrome","volume":"92","author":"Cort\u00f3n","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B32","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1093\/humrep\/dem380","article-title":"Proteomic analysis of human omental adipose tissue in the polycystic ovary syndrome using two-dimensional difference gel electrophoresis and mass spectrometry","volume":"23","author":"Cort\u00f3n","year":"2008","journal-title":"Hum. Reprod."},{"key":"B33","doi-asserted-by":"publisher","first-page":"CD005552","DOI":"10.1002\/14651858.CD005552.pub2","article-title":"Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome","author":"Costello","year":"2007","journal-title":"Cochrane Database Syst. Rev."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/S0140-6736(97)06062-5","article-title":"Fetal growth, length of gestation, and polycystic ovaries in adult life","volume":"350","author":"Cresswell","year":"1997","journal-title":"Lancet"},{"key":"B35","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3109\/00016349209006227","article-title":"Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women","volume":"71","author":"Dahlgren","year":"1992","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"B36","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1210\/jc.2007-1650","article-title":"Granulosa cell survival and proliferation are altered in polycystic ovary syndrome","volume":"93","author":"Das","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1016\/j.fertnstert.2009.09.018","article-title":"Anxiety and depression in polycystic ovary syndrome: a comprehensive investigation","volume":"93","author":"Deeks","year":"2010","journal-title":"Fertil. Steril."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1093\/humrep\/del185","article-title":"Metformin treatment is effective in obese teenage girls with PCOS","volume":"21","author":"De Leo","year":"2006","journal-title":"Hum. Reprod."},{"key":"B39","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1093\/humupd\/dmt061","article-title":"Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society","volume":"20","author":"Dewailly","year":"2014","journal-title":"Hum. Reprod. Update"},{"key":"B40","doi-asserted-by":"publisher","first-page":"3682","DOI":"10.1210\/jc.2009-1608","article-title":"Early Origins of polycystic ovary syndrome: hypotheses may change without notice","volume":"94","author":"de Zegher","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B41","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.tem.2009.06.003","article-title":"Adipose tissue expandability and the early origins of PCOS","volume":"20","author":"de Zegher","year":"2009","journal-title":"Trends Endocrinol. Metab."},{"key":"B42","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.2337\/diacare.25.12.2165","article-title":"The diabetes prevention program (DPP): description of lifestyle intervention","volume":"25","author":"Diabetes Prevention Program (DPP) Research Group","year":"2002","journal-title":"Diabetes Care"},{"key":"B43","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.bpobgyn.2009.09.005","article-title":"PCOS in adolescents","volume":"24","author":"Diamanti-Kandarakis","year":"2010","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1210\/er.2011-1034","article-title":"Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications","volume":"33","author":"Diamanti-Kandarakis","year":"2012","journal-title":"Endocr. Rev."},{"key":"B45","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1111\/j.1365-2265.2007.02954.x","article-title":"Unravelling the phenotypic map of polycystic ovary syndrome (PCOS): a prospective study of 634 women with PCOS","volume":"67","author":"Diamanti-Kandarakis","year":"2007","journal-title":"Clin. Endocrinol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1097\/AOG.0b013e318202b0a4","article-title":"Increased risk for abnormal depression scores in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"117","author":"Dokras","year":"2011","journal-title":"Obstet. Gynecol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1055\/s-2003-43308","article-title":"Polycystic ovary syndrome in adolescence","volume":"21","author":"Driscoll","year":"2003","journal-title":"Semin. Reprod. Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.steroids.2013.04.004","article-title":"Cancer risk and PCOS","volume":"78","author":"Dumesic","year":"2013","journal-title":"Steroids"},{"key":"B49","doi-asserted-by":"publisher","first-page":"33S","DOI":"10.1016\/s0002-9343(99)80057-6","article-title":"Hyperandrogenic anovulation (PCOS): a unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus","volume":"98","author":"Dunaif","year":"1995","journal-title":"Am. J. Med"},{"key":"B50","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1210\/er.18.6.774","article-title":"Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis","volume":"18","author":"Dunaif","year":"1997","journal-title":"Endocr. Rev."},{"key":"B51","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0889-8529(05)70073-6","article-title":"Insulin action in the polycystic ovary syndrome","volume":"28","author":"Dunaif","year":"1999","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"B52","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1210\/jcem-70-3-699","article-title":"Suppression of hyperandrogenism does not improve peripheral or hepatic insulin resistance in the polycystic ovary syndrome","volume":"70","author":"Dunaif","year":"1990","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B53","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1210\/er.16.3.322","article-title":"Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion","volume":"16","author":"Ehrmann","year":"1995","journal-title":"Endocr. Rev."},{"key":"B54","doi-asserted-by":"publisher","first-page":"141","DOI":"10.2337\/diacare.22.1.141","article-title":"Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome","volume":"22","author":"Ehrmann","year":"1999","journal-title":"Diabetes Care"},{"key":"B55","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1210\/jc.82.2.524","article-title":"Effects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndrome","volume":"82","author":"Ehrmann","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1093\/humrep\/dei409","article-title":"Determinants of emotional distress in women with polycystic ovary syndrome","volume":"21","author":"Elsenbruch","year":"2006","journal-title":"Hum. Reprod."},{"key":"B57","doi-asserted-by":"publisher","first-page":"5801","DOI":"10.1210\/jc.2003-030562","article-title":"Quality of life, psychosocial well-being, and sexual satisfaction in women with polycystic ovary syndrome","volume":"88","author":"Elsenbruch","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B58","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1210\/er.2004-0004","article-title":"The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome","volume":"26","author":"Escobar-Morreale","year":"2005","journal-title":"Endocr. Rev."},{"key":"B59","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1373\/clinchem.2011.176396","article-title":"Metabolic heterogeneity in polycystic ovary syndrome is determined by obesity: plasma metabolomic approach using GC-MS","volume":"58","author":"Escobar-Morreale","year":"2012","journal-title":"Clin. Chem."},{"key":"B60","first-page":"168","article-title":"Polycystic ovarian disease (Stein-Leventhal syndrome); etiology and rationale for surgical treatment","volume":"12","author":"Evans","year":"1958","journal-title":"Obstet. Gynecol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.fertnstert.2011.09.024","article-title":"Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group","volume":"97","author":"Fauser","year":"2012","journal-title":"Fertil. Steril."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1210\/jcem-21-11-1440","article-title":"Clinical assessment of body hair growth in women","volume":"21","author":"Ferriman","year":"1961","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B63","first-page":"321","article-title":"Myo-inositol vs. D-chiro inositol in PCOS treatment","volume":"67","author":"Formuso","year":"2015","journal-title":"Minerva Ginecol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1053\/beem.2002.0203","article-title":"Adult polycystic ovary syndrome begins in childhood","volume":"16","author":"Franks","year":"2002","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"B65","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3109\/09513590.2010.538099","article-title":"D-Chiro-inositol and its significance in polycystic ovary syndrome: a systematic review","volume":"27","author":"Galazis","year":"2011","journal-title":"Gynecol. Endocrinol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.1210\/jc.2003-031780","article-title":"Comparison of efficacy of spironolactone with metformin in the management of polycystic ovary syndrome: an open-labeled study","volume":"89","author":"Ganie","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B67","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1210\/jc.2013-1040","article-title":"Improved efficacy of low-dose spironolactone and metformin combination than either drug alone in the management of women with polycystic ovary syndrome (PCOS): a six-month, open-label randomized study","volume":"98","author":"Ganie","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B68","doi-asserted-by":"publisher","first-page":"969","DOI":"10.3109\/09513590.2012.685205","article-title":"Differential insulin response to myo-inositol administration in obese polycystic ovary syndrome patients","volume":"28","author":"Genazzani","year":"2012","journal-title":"Gynecol. Endocrinol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.ejogrb.2005.03.010","article-title":"Obesity and extreme obesity, manifest by ages 20-24 years, continuing through 32-41 years in women, should alert physicians to the diagnostic likelihood of polycystic ovary syndrome as a reversible underlying endocrinopathy","volume":"122","author":"Glueck","year":"2005","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1210\/jc.2005-1696","article-title":"Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome","volume":"91","author":"Gonzalez","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B71","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1093\/humrep\/den433","article-title":"Indicators for metabolic disturbances in anovulatory women with polycystic ovary syndrome diagnosed according to the Rotterdam consensus criteria","volume":"24","author":"Goverde","year":"2009","journal-title":"Hum. Reprod."},{"key":"B72","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1515\/JPEM.2005.18.5.499","article-title":"Approach to adolescent polycystic ovary syndrome (PCOS) in the pediatric endocrine community in the U.S.A","volume":"18","author":"Guttmann-Bauman","year":"2005","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"B73","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1055\/s-2005-870236","article-title":"Clinical and biochemical characterization of women with polycystic ovary syndrome in North Rhine-Westphalia","volume":"37","author":"Hahn","year":"2005","journal-title":"Horm. Metab. Res."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1093\/humrep\/des042","article-title":"Evaluating the association between endometrial cancer and polycystic ovary syndrome","volume":"27","author":"Haoula","year":"2012","journal-title":"Hum. Reprod."},{"key":"B75","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.steroids.2013.04.011","article-title":"Diagnosis of adolescent polycystic ovary syndrome","volume":"78","author":"Hardy","year":"2013","journal-title":"Steroids"},{"key":"B76","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1210\/jc.2014-3886","article-title":"The potential implications of a PCOS diagnosis on a woman's long-term health using data linkage","volume":"100","author":"Hart","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B77","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1016\/j.fertnstert.2011.03.001","article-title":"Extent of metabolic risk in adolescent girls with features of polycystic ovary syndrome","volume":"95","author":"Hart","year":"2011","journal-title":"Fertil. Steril."},{"key":"B78","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.bpobgyn.2006.04.006","article-title":"Polycystic ovarian syndrome\u2013prognosis and outcomes","volume":"20","author":"Hart","year":"2006","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1159\/000079392","article-title":"Prevalence of congenital hypothyroidism in Isfahan, Iran: results of a survey on 20,000 neonates","volume":"62","author":"Hashemipour","year":"2004","journal-title":"Horm. Res."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1093\/humrep\/der102","article-title":"Clinical, ultrasound and biochemical features of polycystic ovary syndrome in adolescents: implications for diagnosis","volume":"26","author":"Hickey","year":"2011","journal-title":"Hum. Reprod."},{"key":"B81","doi-asserted-by":"publisher","first-page":"3714","DOI":"10.1210\/jc.2009-0544","article-title":"The relationship between maternal and umbilical cord androgen levels and polycystic ovary syndrome in adolescence: a prospective cohort study","volume":"94","author":"Hickey","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B82","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.ecl.2005.04.012","article-title":"Oral contraceptives and the management of hyperandrogenism-polycystic ovary syndrome in adolescents","volume":"34","author":"Hillard","year":"2005","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"B83","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1177\/1359105306065021","article-title":"Depression and body image among women with polycystic ovary syndrome","volume":"11","author":"Himelein","year":"2006","journal-title":"J. Health Psychol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1093\/humrep\/deh207","article-title":"Polycystic ovary syndrome in adolescence\u2013a therapeutic conundrum","volume":"19","author":"Homburg","year":"2004","journal-title":"Hum. Reprod."},{"key":"B85","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0015-0282(16)55794-X","article-title":"Gonadotropin-releasing hormone agonist reduces the miscarriage rate for pregnancies achieved in women with polycystic ovarian syndrome","volume":"59","author":"Homburg","year":"1993","journal-title":"Fertil. Steril."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1093\/humrep\/dem028","article-title":"Vascular dysfunction during pregnancy in women with polycystic ovary syndrome","volume":"22","author":"Hu","year":"2007","journal-title":"Hum. Reprod."},{"key":"B87","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.2337\/dc10-1809","article-title":"Lifecourse childhood adiposity trajectories associated with adolescent insulin resistance","volume":"34","author":"Huang","year":"2011","journal-title":"Diabetes Care"},{"key":"B88","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3109\/09513598709023610","article-title":"Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies","volume":"1","author":"Hull","year":"1987","journal-title":"Gynecol. Endocrinol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s11154-008-9096-y","article-title":"Clinical spectrum of premature pubarche: links to metabolic syndrome and ovarian hyperandrogenism","volume":"10","author":"Ibanez","year":"2009","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"B90","doi-asserted-by":"publisher","first-page":"3558","DOI":"10.1210\/jcem.83.10.5205","article-title":"Precocious pubarche, hyperinsulinism, and ovarian hyperandrogenism in girls: relation to reduced fetal growth","volume":"83","author":"Ib\u00e1\u00f1ez","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B91","doi-asserted-by":"publisher","first-page":"3526","DOI":"10.1210\/jc.85.10.3526","article-title":"Sensitization to insulin in adolescent girls to normalize hirsutism, hyperandrogenism, oligomenorrhea, dyslipidemia, and hyperinsulinism after precocious pubarche","volume":"85","author":"Ib\u00e1\u00f1ez","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B92","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1210\/jc.83.7.2361","article-title":"Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility","volume":"83","author":"Imani","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B93","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1093\/humrep\/dep384","article-title":"Anxiety and depression symptoms in women with polycystic ovary syndrome compared with controls matched for body mass index","volume":"25","author":"Jedel","year":"2010","journal-title":"Hum. Reprod."},{"key":"B94","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/humupd\/dmm030","article-title":"Health-related quality of life measurement in women with polycystic ovary syndrome: a systematic review","volume":"14","author":"Jones","year":"2008","journal-title":"Hum. Reprod. Update"},{"key":"B95","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0015-0282(00)01662-9","article-title":"Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS","volume":"75","author":"Kahsar-Miller","year":"2001","journal-title":"Fertil. Steril."},{"key":"B96","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0960-0760(03)00268-1","article-title":"Comparative studies on the regulation of insulin-like growth factor-binding protein-1 (IGFBP-1) and sex hormone-binding globulin (SHBG) production by insulin and insulin-like growth factors in human hepatoma cells","volume":"86","author":"Kalme","year":"2003","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/pde.12566","article-title":"Polycystic ovary syndrome: special diagnostic and therapeutic considerations for children","volume":"32","author":"Kamangar","year":"2015","journal-title":"Pediatr. Dermatol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3109\/09513590.2011.589929","article-title":"Evaluation of body fat distribution in PCOS and its association with carotid atherosclerosis and insulin resistance","volume":"28","author":"Karabulut","year":"2012","journal-title":"Gynecol. Endocrinol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3109\/09513590.2014.974535","article-title":"Pregnancy complications in polycystic ovary syndrome patients","volume":"31","author":"Katulski","year":"2015","journal-title":"Gynecol. Endocrinol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1210\/jcem-70-2-473","article-title":"Androgen-estrogen metabolism in women with upper body versus lower body obesity","volume":"70","author":"Kirschner","year":"1990","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B101","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"B102","doi-asserted-by":"publisher","first-page":"3533","DOI":"10.1210\/jc.2011-1609","article-title":"Effect of lifestyle intervention on features of polycystic ovarian syndrome, metabolic syndrome, and intima-media thickness in obese adolescent girls","volume":"96","author":"Lass","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B103","doi-asserted-by":"publisher","first-page":"555","DOI":"10.4140\/TCP.n.2014.555","article-title":"The impact of pioglitazone on bladder cancer and cardiovascular events","volume":"29","author":"Lee","year":"2014","journal-title":"Consult. Pharm."},{"key":"B104","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12916-015-0299-2","article-title":"Diagnosis and treatment of polycystic ovary syndrome (PCOS): an interview with Richard Legro","volume":"13","author":"Legro","year":"2015","journal-title":"BMC Med."},{"key":"B105","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1210\/er.2003-0004","article-title":"Polycystic ovary syndrome and cardiovascular disease: a premature association?","volume":"24","author":"Legro","year":"2003","journal-title":"Endocr. Rev."},{"key":"B106","doi-asserted-by":"publisher","first-page":"4565","DOI":"10.1210\/jc.2013-2350","article-title":"Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline","volume":"98","author":"Legro","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B107","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/01.OGX.0000109523.25076.E2","article-title":"Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls","volume":"59","author":"Legro","year":"2004","journal-title":"Obstet. Gynecol. Surv."},{"key":"B108","doi-asserted-by":"publisher","first-page":"14956","DOI":"10.1073\/pnas.95.25.14956","article-title":"Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome","volume":"95","author":"Legro","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B109","doi-asserted-by":"publisher","first-page":"3236","DOI":"10.1210\/jc.2004-1843","article-title":"Changes in glucose tolerance over time in women with polycystic ovary syndrome: a controlled study","volume":"90","author":"Legro","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B110","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1097\/00006254-199906000-00019","article-title":"Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women","volume":"84","author":"Legro","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B111","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1093\/humrep\/det255","article-title":"Assessment of glucose metabolism in polycystic ovary syndrome: HbA1c or fasting glucose compared with the oral glucose tolerance test as a screening method","volume":"28","author":"Lerchbaum","year":"2013","journal-title":"Hum. Reprod."},{"key":"B112","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s00125-014-3456-9","article-title":"Pioglitazone and bladder cancer risk: a multipopulation pooled, cumulative exposure analysis","volume":"58","author":"Levin","year":"2015","journal-title":"Diabetologia"},{"key":"B113","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.fertnstert.2011.05.072","article-title":"Polycystic ovary syndrome is associated with negatively variable impacts on domains of health-related quality of life: evidence from a meta-analysis","volume":"96","author":"Li","year":"2011","journal-title":"Fertil. Steril."},{"key":"B114","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1056\/NEJMoa1111840","article-title":"Thrombotic stroke and myocardial infarction with hormonal contraception","volume":"366","author":"Lidegaard","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"B115","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1210\/jc.2011-1896","article-title":"Insulin resistance is a sufficient basis for hyperandrogenism in lipodystrophic women with polycystic ovarian syndrome","volume":"97","author":"Lungu","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B116","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1530\/eje.1.02331","article-title":"Rosiglitazone treatment increases plasma levels of adiponectin and decreases levels of resistin in overweight women with PCOS: a randomized placebo-controlled study","volume":"156","author":"Majuri","year":"2007","journal-title":"Eur. J. Endocrinol."},{"key":"B117","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1093\/humrep\/deq162","article-title":"High prevalence of polycystic ovary syndrome in women born small for gestational age","volume":"25","author":"Melo","year":"2010","journal-title":"Hum. Reprod."},{"key":"B118","doi-asserted-by":"publisher","first-page":"850","DOI":"10.3109\/09513590.2014.943725","article-title":"Hormonal contraceptive choice for women with PCOS: a systematic review of randomized trials and observational studies","volume":"30","author":"Mendoza","year":"2014","journal-title":"Gynecol. Endocrinol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"4630","DOI":"10.1210\/jc.2004-1487","article-title":"Vascular dysfunction and metabolic parameters in polycystic ovary syndrome","volume":"90","author":"Meyer","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B120","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1055\/s-0034-1371095","article-title":"Development of evidenced-based guidelines for PCOS and implications for community health","volume":"32","author":"Misso","year":"2014","journal-title":"Semin. Reprod. Med."},{"key":"B121","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0022-3476(83)80678-7","article-title":"Plasma free testosterone in the diagnosis of adolescent polycystic ovary syndrome","volume":"102","author":"Moll","year":"1983","journal-title":"J. Pediatr."},{"key":"B122","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1042\/CS20080218","article-title":"A comprehensive assessment of endothelial function in overweight women with and without polycystic ovary syndrome","volume":"116","author":"Moran","year":"2009","journal-title":"Clin. Sci."},{"key":"B123","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1093\/humupd\/dmq001","article-title":"Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"16","author":"Moran","year":"2010","journal-title":"Hum. Reprod. Update"},{"key":"B124","first-page":"457","article-title":"Polycystic ovary syndrome (PCOS) and hyperandrogenism: the role of a new natural association","volume":"67","author":"Morgante","year":"2015","journal-title":"Minerva Ginecol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1016\/j.fertnstert.2011.01.035","article-title":"The role of inositol supplementation in patients with polycystic ovary syndrome, with insulin resistance, undergoing the low-dose gonadotropin ovulation induction regimen","volume":"95","author":"Morgante","year":"2011","journal-title":"Fertil. Steril."},{"key":"B126","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/S0015-0282(98)00011-9","article-title":"Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome","volume":"69","author":"Morin-Papunen","year":"1998","journal-title":"Fertil. Steril."},{"key":"B127","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1210\/jc.2008-2771","article-title":"Asymptomatic volunteers with a polycystic ovary are a functionally distinct but heterogeneous population","volume":"94","author":"Mortensen","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B128","first-page":"528","article-title":"Insulin resistance assessment in patients with polycystic ovary syndrome using different diagnostic criteria\u2013impact of metformin treatment","volume":"20","author":"Nawrocka-Rutkowska","year":"2013","journal-title":"Ann. Agric. Environ. Med."},{"key":"B129","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1210\/mend.13.6.0311","article-title":"Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries","volume":"13","author":"Nelson","year":"1999","journal-title":"Mol. Endocrinol."},{"key":"B130","first-page":"575","article-title":"The combined therapy with myo-inositol and D-chiro-inositol reduces the risk of metabolic disease in PCOS overweight patients compared to myo-inositol supplementation alone","volume":"16","author":"Nordio","year":"2012","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"B131","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0140-6736(07)61345-2","article-title":"Polycystic ovary syndrome","volume":"370","author":"Norman","year":"2007","journal-title":"Lancet"},{"key":"B132","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1016\/j.fertnstert.2008.01.088","article-title":"Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial","volume":"91","author":"Papaleo","year":"2009","journal-title":"Fertil. Steril."},{"key":"B133","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1111\/j.1471-0528.2006.00990.x","article-title":"The impact of obesity on reproduction in women with polycystic ovary syndrome","volume":"113","author":"Pasquali","year":"2006","journal-title":"BJOG"},{"key":"B134","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1111\/j.1365-2265.2010.03956.x","article-title":"PCOS Forum: research in polycystic ovary syndrome today and tomorrow","volume":"74","author":"Pasquali","year":"2011","journal-title":"Clin. Endocrinol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1210\/jc.2013-4021","article-title":"Metformin improves glucose effectiveness, not insulin sensitivity: predicting treatment response in women with polycystic ovary syndrome in an open-label, interventional study","volume":"99","author":"Pau","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B136","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1210\/jc.2006-1582","article-title":"Granulosa cell production of anti-Mullerian hormone is increased in polycystic ovaries","volume":"92","author":"Pellatt","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B137","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S0889-8545(03)00028-7","article-title":"Treatment of the adolescent patient with polycystic ovary syndrome","volume":"30","author":"Pfeifer","year":"2003","journal-title":"Obstet. Gynecol. Clin. North Am."},{"key":"B138","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S0895-4356(98)00035-3","article-title":"Mortality of women with polycystic ovary syndrome at long-term follow-up","volume":"51","author":"Pierpoint","year":"1998","journal-title":"J. Clin. Epidemiol."},{"key":"B139","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jpag.2014.03.002","article-title":"Trends in standard workup performed by pediatric subspecialists for the diagnosis of adolescent polycystic ovary syndrome","volume":"28","author":"Powers","year":"2015","journal-title":"J. Pediatr. Adolesc. Gynecol."},{"key":"B140","first-page":"913","article-title":"Effect of myo-inositol and alpha-lipoic acid on oocyte quality in polycystic ovary syndrome non-obese women undergoing in vitro fertilization: a pilot study","volume":"29","author":"Rago","year":"2015","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"B141","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1210\/er.2012-1003","article-title":"Cardiometabolic aspects of the polycystic ovary syndrome","volume":"33","author":"Randeva","year":"2012","journal-title":"Endocr. Rev."},{"key":"B142","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/1475-2840-11-145","article-title":"Early signs of atherosclerosis are associated with insulin resistance in non-obese adolescent and young adults with type 1 diabetes","volume":"11","author":"Rathsman","year":"2012","journal-title":"Cardiovasc. Diabetol."},{"key":"B143","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1093\/humrep\/dep121","article-title":"Milder forms of atherogenic dyslipidemia in ovulatory versus anovulatory polycystic ovary syndrome phenotype","volume":"24","author":"Rizzo","year":"2009","journal-title":"Hum. Reprod."},{"key":"B144","doi-asserted-by":"publisher","first-page":"3572","DOI":"10.1210\/jc.2013-1770","article-title":"Clinical review: adolescent anovulation: maturational mechanisms and implications","volume":"98","author":"Rosenfield","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B145","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","author":"Rotterdam","year":"2004","journal-title":"Hum. Reprod."},{"key":"B146","doi-asserted-by":"publisher","first-page":"4546","DOI":"10.1210\/jc.2007-1549","article-title":"Glucose intolerance in polycystic ovary syndrome\u2013a position statement of the Androgen Excess Society","volume":"92","author":"Salley","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B147","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1530\/EJE-11-0755","article-title":"Recent advances in cardiovascular aspects of polycystic ovary syndrome","volume":"166","author":"Sathyapalan","year":"2012","journal-title":"Eur. J. Endocrinol."},{"key":"B148","doi-asserted-by":"publisher","first-page":"3794","DOI":"10.1210\/jc.2011-1677","article-title":"Cardiovascular disease and risk factors in PCOS women of postmenopausal age: a 21-year controlled follow-up study","volume":"96","author":"Schmidt","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B149","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1210\/jc.2010-0518","article-title":"Is there a genetic basis for polycystic ovary syndrome?","volume":"95","author":"Segars","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B150","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1210\/jc.2007-0425","article-title":"Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health\u2013National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation","volume":"93","author":"Shaw","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B151","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jpag.2014.05.006","article-title":"Diagnostic characteristics and metabolic risk factors of cases with polycystic ovary syndrome during adolescence","volume":"28","author":"Siklar","year":"2015","journal-title":"J. Pediatr. Adolesc. Gynecol."},{"key":"B152","doi-asserted-by":"publisher","first-page":"919","DOI":"10.4067\/S0034-98872012000700015","article-title":"Polycystic ovary syndrome and pregnancy","volume":"140","author":"Sir-Petermann","year":"2012","journal-title":"Rev. Med. Chil."},{"key":"B153","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3322\/canjclin.51.1.38","article-title":"American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. Also: update 2001\u2013testing for early lung cancer detection","volume":"51","author":"Smith","year":"2001","journal-title":"CA Cancer J. Clin."},{"key":"B154","first-page":"195","article-title":"Novel strategies in the management of polycystic ovary syndrome","volume":"40","author":"Spritzer","year":"2015","journal-title":"Minerva Endocrinol."},{"key":"B155","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jpag.2013.09.015","article-title":"Effects of the insulin sensitizer pioglitazone on menstrual irregularity, insulin resistance and hyperandrogenism in young women with polycystic ovary syndrome","volume":"27","author":"Stabile","year":"2014","journal-title":"J. Pediatr. Adolesc. Gynecol."},{"key":"B156","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0002-9378(15)30642-6","article-title":"Amenorrhea associated with bilateral polycystic ovaries","volume":"29","author":"Stein","year":"1935","journal-title":"Am. J. Obstet. Gynecol."},{"key":"B157","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1093\/humrep\/des463","article-title":"Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp","volume":"28","author":"Stepto","year":"2013","journal-title":"Hum. Reprod."},{"key":"B158","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1089\/jwh.2006.0098","article-title":"Polycystic ovarian syndrome (PCOS): a significant contributor to the overall burden of type 2 diabetes in women","volume":"16","author":"Talbott","year":"2007","journal-title":"J. Womens Health (Larchmt)"},{"key":"B159","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1093\/humrep\/dei311","article-title":"Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study","volume":"21","author":"Tang","year":"2006","journal-title":"Hum. Reprod."},{"key":"B160","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1741-7015-8-41","article-title":"Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan","volume":"8","author":"Teede","year":"2010","journal-title":"BMC Med."},{"key":"B161","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.5694\/mja11.10915","article-title":"Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline","volume":"195","author":"Teede","year":"2011","journal-title":"Med. J. Aust."},{"key":"B162","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1196\/annals.1429.024","article-title":"Menstrual health and the metabolic syndrome in adolescents","volume":"1135","author":"Tfayli","year":"2008","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"B163","doi-asserted-by":"publisher","first-page":"4191","DOI":"10.1210\/jc.2007-0761","article-title":"Identification of a polycystic ovary syndrome susceptibility variant in fibrillin-3 and association with a metabolic phenotype","volume":"92","author":"Urbanek","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B164","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1210\/jc.85.4.1394","article-title":"Insulin, androgen, and gonadotropin concentrations, body mass index, and waist to hip ratio in the first years after menarche in girls with regular menstrual cycles, irregular menstrual cycles, or oligomenorrhea","volume":"85","author":"Van Hooff","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B165","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/0026-0495(94)90209-7","article-title":"Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy","volume":"43","author":"Velazquez","year":"1994","journal-title":"Metabolism"},{"key":"B166","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1093\/humupd\/dms029","article-title":"Emotional distress is a common risk in women with polycystic ovary syndrome: a systematic review and meta-analysis of 28 studies","volume":"18","author":"Veltman-Verhulst","year":"2012","journal-title":"Hum. Reprod. Update"},{"key":"B167","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1203\/00006450-199512000-00024","article-title":"Longitudinal change of sonographic ovarian aspects and endocrine parameters in irregular cycles of adolescence","volume":"38","author":"Venturoli","year":"1995","journal-title":"Pediatr. Res."},{"key":"B168","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1530\/EJE-07-0286","article-title":"Impact of fetal growth restriction on body composition and hormonal status at birth in infants of small and appropriate weight for gestational age","volume":"157","author":"Verkauskiene","year":"2007","journal-title":"Eur. J. Endocrinol."},{"key":"B169","doi-asserted-by":"publisher","first-page":"3505","DOI":"10.1210\/jc.2009-0466","article-title":"Mitochondrial complex I impairment in leukocytes from polycystic ovary syndrome patients with insulin resistance","volume":"94","author":"Victor","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B170","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1093\/humrep\/der223","article-title":"Polycystic ovarian morphology in adolescents with regular menstrual cycles is associated with elevated anti-Mullerian hormone","volume":"26","author":"Villarroel","year":"2011","journal-title":"Hum. Reprod."},{"key":"B171","doi-asserted-by":"publisher","first-page":"E114","DOI":"10.1210\/jc.2010-1709","article-title":"Menstrual irregularity and cardiovascular mortality","volume":"96","author":"Wang","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B172","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1093\/humrep\/16.12.2606","article-title":"Polycystic ovarian syndrome and the risk of spontaneous abortion following assisted reproductive technology treatment","volume":"16","author":"Wang","year":"2001","journal-title":"Hum. Reprod."},{"key":"B173","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/S0140-6736(03)14410-8","article-title":"Formation and early development of follicles in the polycystic ovary","volume":"362","author":"Webber","year":"2003","journal-title":"Lancet"},{"key":"B174","doi-asserted-by":"publisher","first-page":"219","DOI":"10.2147\/DMSO.S33478","article-title":"Prediction of insulin resistance with anthropometric measures: lessons from a large adolescent population","volume":"5","author":"Wedin","year":"2012","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"B175","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1097\/01.psy.0000127871.46309.fe","article-title":"Androgens and mood dysfunction in women: comparison of women with polycystic ovarian syndrome to healthy controls","volume":"66","author":"Weiner","year":"2004","journal-title":"Psychosom. Med."},{"key":"B176","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1080\/00016340802478166","article-title":"Prospective follow-up of menstrual disorders in adolescence and prognostic factors","volume":"87","author":"Wiksten-Almstromer","year":"2008","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"B177","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1210\/jc.2009-2724","article-title":"Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society","volume":"95","author":"Wild","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B178","doi-asserted-by":"publisher","first-page":"3220","DOI":"10.1093\/humrep\/17.12.3220","article-title":"Early pregnancy loss following assisted reproductive technology treatment","volume":"17","author":"Winter","year":"2002","journal-title":"Hum. Reprod."},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1159\/000375530.","article-title":"The diagnosis of polycystic ovary syndrome during adolescence","author":"Witchel","year":"2015","journal-title":"Horm. Res. Paediatr."},{"key":"B180","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/ncpendmet0789","article-title":"Assessment, diagnosis and treatment of a patient with hirsutism","volume":"4","author":"Yildiz","year":"2008a","journal-title":"Nat. Clin. Pract. Endocrinol. Metab."},{"key":"B181","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1055\/s-2007-992931","article-title":"Oral contraceptives in polycystic ovary syndrome: risk-benefit assessment","volume":"26","author":"Yildiz","year":"2008b","journal-title":"Semin. Reprod. Med."},{"key":"B182","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1210\/jc.2014-3196","article-title":"Approach to the patient: contraception in women with polycystic ovary syndrome","volume":"100","author":"Yildiz","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B183","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1016\/j.fertnstert.2006.05.045","article-title":"Heritability of dehydroepiandrosterone sulfate in women with polycystic ovary syndrome and their sisters","volume":"86","author":"Yildiz","year":"2006","journal-title":"Fertil. Steril."},{"key":"B184","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.1093\/humrep\/dei258","article-title":"The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome","volume":"20","author":"Yilmaz","year":"2005","journal-title":"Hum. Reprod."},{"key":"B185","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1111\/j.1471-0528.2009.02347.x","article-title":"Characteristics of different phenotypes of polycystic ovary syndrome based on the Rotterdam criteria in a large-scale Chinese population","volume":"116","author":"Zhang","year":"2009","journal-title":"BJOG"}],"container-title":["Frontiers in Physiology"],"original-title":[],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T06:06:25Z","timestamp":1498284385000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fphys.2016.00124\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,5]]},"references-count":185,"URL":"https:\/\/doi.org\/10.3389\/fphys.2016.00124","relation":{},"ISSN":["1664-042X"],"issn-type":[{"value":"1664-042X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,5]]}}}